• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall IRON, IRON, Alinity c Iron Reagent

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall IRON, IRON, Alinity c Iron Reagent see related information
Date Initiated by Firm September 29, 2023
Date Posted November 17, 2023
Recall Status1 Open3, Classified
Recall Number Z-0325-2024
Recall Event ID 93298
Product Classification Photometric method, iron (non-heme) - Product Code JIY
Product IRON assay, Reference Numbers 6K95-41 and 6K95-30
Code Information Reference Number 6K95-41: UDI-DI: 00380740010928; Lot Number: 30610Y600; Reference Number 6K95-30: UDI-DI: 00380740010911; Lot Numbers: 21058Y600, 21101Y600, 30918Y600
Recalling Firm/
Manufacturer
Sentinel CH SpA
Via Robert Koch 2
Milan Italy
Manufacturer Reason
for Recall
A high recovery of Iron assay has been observed at some customer sites. Internal studies confirmed the positive shift of Quality Control and patient samples results, up to 15% for Iron Products (Alinity c Iron Reagent REF. 08P3920) to be used on Abbott Alinity Instrument and to 30% for Iron Products (IRON REF. 6K95-41 and IRON REF. 6K95- 30) to be used on Abbott Architect Instrument. When using the affected lots, there is a potential for delay in reporting patient results due to QC failure, also a potential for falsely elevated results.
FDA Determined
Cause 2
Under Investigation by firm
Action A Field Safety Notice letter dated 9/29/23 was sent to customers. Actions to be taken: " Discontinue the use of and destroy any remaining inventory of the affected lots listed above of IRON for use with ARCHITECT REF 6K95-41, REF 6K95-30 and Alinity c Iron Reagent Kit REF 08P3920 according to your laboratory procedures. " Review this letter with your Medical Director or Laboratory Management and follow your laboratory protocol regarding the need for reviewing previously reported patient results. Results should always be assessed in conjunction with the patient's medical history, clinical examination and other biochemical tests as suggested by clinical guidelines. " Complete and return the Abbott Customer Reply Form. " Please retain this letter for your laboratory records. Transmission of this Field Safety Notice: This notice needs to be passed on to all those who need to be aware within your organization or to any organization/individuals where the potentially affected devices have been transferred. If you or any of your customers have any questions regarding this information, please contact your local area Abbott Customer Service.
Quantity in Commerce 4394 kits
Distribution Worldwide - US Nationwide distribution.
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
-
-